"10.1371_journal.pone.0084088","plos one","2013-12-19T00:00:00Z","Aurelie Millier; Joshua Cohen; Mondher Toumi","Health Economics and Outcomes Research Department, Creativ-Ceutical, Paris, France; Tufts Center for the Study of Drug Development, Tufts University, Boston, Massachusetts, United States of America; Unité de Formation et de Recherche dOdontologie, Université Claude Bernard Lyon I, Lyon, France","Conceived and designed the experiments: AM JC MT. Performed the experiments: AM JC MT. Analyzed the data: AM JC MT. Contributed reagents/materials/analysis tools: AM JC MT. Wrote the manuscript: AM JC MT.","Aurélie Millier is an employee from Creativ-Ceutical, which received funding from Sanofi. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.","2013","12","Aurelie Millier","AM",3,TRUE,3,3,3,3,TRUE,TRUE,FALSE,0,NA,FALSE
